StockDrifts LogoStockDrifts

Venrock Adviser LLC

Portfolio Manager
Venrock Adviser LLC
Performance
+25.05% (2026 Q1)
AUM (13F)
$2.68B
# of Holdings
33
Performance Rank
Allocation (Top 20)
91.1%

Venrock Adviser LLC Holdings Map

Top 33 Venrock Adviser LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
APGE
APOGEE THERAPEUTICS INC
26.68%8.49M$714.9M
+0.00%(+0)
2025-Q1: 8.49M shares2025-Q2: 8.49M shares2025-Q3: 8.49M shares2025-Q4: 8.49M shares2026-Q1: 8.49M shares
$21.30(+523.99%)
2026-03-31
ERAS
ERASCA INC
9.89%16.38M$265.1M
-8.26%(-1.47M)
2025-Q1: 16.22M shares2025-Q2: 17.86M shares2025-Q3: 17.86M shares2025-Q4: 17.86M shares2026-Q1: 16.38M shares
$2.14(+765.06%)
2026-03-31
ORKA
ORUKA THERAPEUTICS INC
7.6%4.15M$203.5M
+0.00%(+0)
2025-Q1: 4.15M shares2025-Q2: 4.15M shares2025-Q3: 4.15M shares2025-Q4: 4.15M shares2026-Q1: 4.15M shares
$30.35(+180.76%)
2026-03-31
SYRE
SPYRE THERAPEUTICS INC
6.94%3.69M$185.9M
+0.00%(+0)
2025-Q1: 2.69M shares2025-Q2: 2.69M shares2025-Q3: 2.69M shares2025-Q4: 3.69M shares2026-Q1: 3.69M shares
$20.42(+324.28%)
2026-03-31
KALV
KALVISTA PHARMACEUTICALS INC
4.86%6.47M$130.3M
-3.78%(-254.50K)
2025-Q1: 6.70M shares2025-Q2: 6.73M shares2025-Q3: 6.73M shares2025-Q4: 6.73M shares2026-Q1: 6.47M shares
$11.10(+140.71%)
2026-03-31
DNTH
DIANTHUS THERAPEUTICS INC
3.7%1.18M$99.0M
+18.00%(+180.00K)
2025-Q1: 1.74M shares2025-Q2: 1.00M shares2025-Q3: 960.8K shares2025-Q4: 1.00M shares2026-Q1: 1.18M shares
$24.70(+281.91%)
2026-03-31
DMRA
DAMORA THERAPEUTICS INC
3.48%3.60M$93.3Mnew2025-Q1: 0 shares2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 3.60M shares
$24.45(+22.59%)
2026-03-31
OCUL
OCULAR THERAPEUTIX INC
3.27%10.35M$87.6M
+41.44%(+3.03M)
2025-Q1: 12.76M shares2025-Q2: 12.76M shares2025-Q3: 13.16M shares2025-Q4: 7.32M shares2026-Q1: 10.35M shares
$6.65(+45.02%)
2026-03-31
COGT
COGENT BIOSCIENCES INC
2.87%2.00M$77.0M
+0.00%(+0)
2025-Q1: 5.68M shares2025-Q2: 4.76M shares2025-Q3: 4.00M shares2025-Q4: 2.00M shares2026-Q1: 2.00M shares
$8.83(+337.92%)
2026-03-31
VRDN
VIRIDIAN THERAPEUTICS INC
2.83%3.88M$75.9M
+0.00%(+0)
2025-Q1: 3.88M shares2025-Q2: 3.88M shares2025-Q3: 3.88M shares2025-Q4: 3.88M shares2026-Q1: 3.88M shares
$19.66(-1.32%)
2026-03-31

Unlock alerts, watchlists & AI chat

Sign up free to track Venrock Adviser LLC, compare funds side by side, and get alerts the moment positions change.

More 13F analyses

View all